Products

You can also try the following methods, and our professionals will serve you Customized Consultation

Cat. No.	Product Name	Field of Application
DC8609	GW843682X Featured	GW843682X is a cell-permeable thiophene-benzimidazole compound and reversible PLK inhibitor
DC22653	GW-8510 Featured	GW-8510 (GW8510) is a potent, selective inhibitor of CDK2 with IC50 of 10 nM.
DC1086	GW-9508 Featured	GW9508 is a potent and selective agonist for FFA1 (GPR40) with pEC50 of 7.32.
DC2079	GW-9662 Featured	GW9662 is a selective PPAR antagonist, inhibiting PPARγ, PPARα and PPARδ with IC50 of 3.3 nM, 32 nM and 2 μM, respectively.
DC11993	GWJ-A-23	GWJ-A-23 (GWJ-23, GWJ23) is a potent, selective autotaxin inhibitor with Ki of 18 nM, an analog of the known ATX inhibitor S32826 and has improved aqueous solubility compared with the parent compound.
DC26080	GX-674 Featured	GX-674 is a potent, selective Nav1.7 inhibitor with IC50 of 0.1 nM.
DC23613	GX-936	GX-936 (PF 05196233) is a potent Nav1.7 inhibitor that binds to the activated state of voltage-sensor domain IV (VSD4), exhibits robust inhibition of the 1KαPMTX-evoked N1742K response with IC50 of 40 nM.
DC5061	GYKI 52466 dihydrochloride	GYKI 52466 dihydrochloride is a selective non-competitive AMPA receptor antagonist (IC50 values are 10-20, ~ 450 and >> 50 μM for AMPA- , kainate- and NMDA-induced responses respectively). Skeletal muscle relaxant and orally-active anticonvulsant.
DC10668	GYY4137 morpholine salt Featured	GYY 4137 is a Water-soluble, slow-releasing hydrogen sulfide donor.
DC22106	GZ389988	GZ389988 (GZ-389988) is a novel potent, selective, locally delivered TrkA inhibitor for the treatment osteoarthritis.
DC7147	GZD824 Featured	GZD824 is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.
DC20118	GZD856 Featured	GZD856 is a novel and orally bioavailable PDGFRα/β inhibitor with IC50s of 68.6 and 136.6 nM, respectively. Anti-lung cancer activities. Also a Bcr-AblT315I inhibitor with IC50s of 19.9 and 15.4 nM for Bcr-Abl and T315I mutant.
DC7835	H-89 2HCl Featured	H 89 2HCl is a potent PKA inhibitor with Ki of 48 nM, 10-fold selective for PKA than PKG, greater than 500-fold selectivity than PKC, MLCK, calmodulin kinase II and casein kinase I/II.
DC10876	H-151 Featured	H-151(H151) is a novel STING (stimulator of interferon genes) antagonist.
DC11010	H3B-5942	H3B-5942 is an orally available, selective estrogen receptor covalent antagonist (SERCA), demonstrates potent ERαantagonist activity in vitro and in vivo.
DC10033	H3B-6527 Featured	H3B-6527 is an orally bioavailable inhibitor of human fibroblast growth factor receptor 4 (FGFR4), with potential antineoplastic activity.
DC21105	H3B-8800 Featured	H3B8800 is an orally available splicing modulator that targets spliceosome SF3b complex containing either WT or mutant SF3B1 (binding IC50 of 0.3-2 nM),demonstrates dose-dependent inhibition of both canonical splicing and aberrant splicing induced by mutant SF3B1 in in vitro assays of biochemical splicing, induces lethality in spliceosome-mutant cancer cells.. H3B-8800 potently and preferentially kills spliceosome-mutant epithelial and hematologic tumor cells.
DC12266	H4 Receptor antagonist 1	H4 Receptor antagonist 1 is a potent and selective histamine H4 receptor inverse agonist, with an IC50 of 19 nM.
DC20106	H4R antagonist 1	H4R antagonist 1
DC8563	HA130 Featured	HA130 is a selective ATX (autotaxin) inhibitor with IC50 of 28 nM.
DC1066	HA14-1 Featured	HA14-1 is a nonpeptidic ligand of a Bcl-2 surface pocket with IC50 of~9 μM.
DC9795	HA-15 Featured	HA15 displayed anti-cancerous activity on all melanoma cells tested, including cells isolated from patients and cells that developed resistance to BRAF inhibitors.
DC9567	Halcinonide	Halcinonide is a high potency corticosteroid used topically in the treatment of certain skin conditions.
DC9749	Halofuginone	Halofuginone is the competitively inhibitor of prolyl-tRNA synthetase with Ki of 18.3 nM.It could also down-regulate Smad3 and blocked TGF-β signaling at 10 ng/ml in mammal.
DCAPI1229	Haloperidol (Haldol)	Haloperidol (Haldol)
DC10935	HAMI3379	HAMI3379 (HAMI-3379) is a potent and selective antagonist of cysteinyl leukotriene 2 (CysLT(2)) receptor, inhibits LTD4- and LTC4-induced intracellular calcium mobilization withIC50 of 3.8 nM and 4.4 nM respectively.
DC10741	HAMNO (NSC111847) Featured	HAMNO is a novel protein interaction inhibitor of replication protein A (RPA).
DC21106	HAP-12	HAP-12 is a small molecule HBV capsid assembly effector that inhibits HBV DNA replication with EC50 of 0.5 uM..
DC23253	HAR-171	HAR-171 is a small molecule gp120-CD40 blocker that acts as a highly potent HIV entry inhibitor with IC50 of 0.43 uM against YTA48P virus with no significant cytotoxicity (CC50>120 uM)..
DC12224	H-Arg-4MβNA	H-Arg-4MβNA is a substrate for cathepsin H, used for the detection of enzyme activity in gel electrophoresis.

Products

Customized Consultation X

Your information is safe with us. * Required Fields.